TRVI
Trevi Therapeutics Inc.
$10.99
+$0.34(+3.19%)
49
Overall
45
Value
54
Tech
--
Quality
Market Cap
$1.28B
Volume
1.27M
52W Range
$2.36 - $12.30
Target Price
$20.36
EPS Estimates Overview
| Current Quarter | $-0.11 | Next Quarter | $-0.12 |
| Current Year | $-0.39 | Next Year | $-0.54 |
| QoQ Growth | -9.1% | YoY Growth | -38.5% |
| 3Y EPS CAGR | N/A | Target Price | $20.36 |
| Consensus | Buy | Upside | +85.3% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $10.99 | +3.2% | 1.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |